Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood

Fertility and Sterility

Volumn 100, Issue 1, 2013, Pages 2-11

  Abbott, David H ^a   Bacha, Fida ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

childhood obesity; developmental programming; Fetal androgen excess; gestational hyperglycemia; insulin resistance

Indexed keywords

HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; RAB PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHILDHOOD DISEASE; CHILDHOOD OBESITY; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; GENETIC PREDISPOSITION; GENOTYPE; HERITABILITY; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; NONHUMAN; OBESITY; ONTOGENY; OVARY POLYCYSTIC DISEASE; OVERNUTRITION; PATHOGENESIS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84879615898     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.05.023     Document Type: Review

References (160)

1. T.B. Eilertsen, E. Vanky, and S.M. Carlsen Anti-müllerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? Hum Reprod 27 2012 2494 2502
2. B.C. Fauser, B.C. Tarlatzis, R.W. Rebar, R.S. Legro, A.H. Balen, and R. Lobo Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored Third PCOS Consensus Workshop Group Fertil Steril 97 2012 28 38
3. T. Hampton NIH panel: name change, new priorities advised for polycystic ovary syndrome JAMA 309 2013 863
4. J.K. Zawadski, and A. Dunaif Diagnostic criteria for poly- cystic ovary syndrome; toward a rational approach A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, Polycystic ovary syndrome 1992 Blackwell Scientific Publications Boston 377 384
5. N. Xita, and A. Tsatsoulis Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies J Clin Endocrinol Metab 91 2006 1660 1666
6. S. Franks Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction Endocrinology 153 2012 2536 2538
7. S. Franks, and S.L. Berga Does PCOS have developmental origins? Fertil Steril 97 2012 2 6
8. D.H. Abbott, L.E. Nicol, J.E. Levine, N. Xu, M.O. Goodarzi, and D.A. Dumesic Nonhuman primate models of polycystic ovary syndrome Mol Cell Endocrinol 373 2013 21 28
9. Å. Nybacka, K. Carlström, A. Ståhle, S. Nyrén, P.M. Hellström, and A.L. Hirschberg Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome Fertil Steril 96 2011 1508 1513
10. R.S. Legro Obesity and PCOS: implications for diagnosis and treatment Semin Reprod Med 30 2012 496 506
11. C. Moran, M. Arriaga, G. Rodriguez, and S. Moran Obesity differentially affects phenotypes of polycystic ovary syndrome Int J Endocrinol 2012 2012 317241
12. S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr Rev 30 2009 1 50
13. E. Carmina, A.M. Campagna, and R.A. Lobo A 20-year follow-up of young women with polycystic ovary syndrome Obstet Gynecol 119 2012 263 269
14. H.F. Escobar-Morreale Surgical management of metabolic dysfunction in PCOS Steroids 77 2012 312 316
15. L.J. Moran, S.K. Hutchison, R.J. Norman, and H.J. Teede Lifestyle changes in women with polycystic ovary syndrome Cochrane Database Syst Rev 7 2011 CD007506
16. S.S. Lim, R.J. Norman, M.J. Davies, and L.J. Moran The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis Obes Rev 14 2013 95 109
17. R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, and W. Futterweit Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society J Clin Endocrinol Metab 95 2010 2038 2049
18. H. Mani, M.J. Levy, M.J. Davies, D.H. Morris, L.J. Gray, and J. Bankart Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study Clin Endocrinol (Oxf) 78 2013 926 934
19. D.H. Abbott, D.A. Dumesic, J.R. Eisner, R.J. Colman, and J.W. Kemnitz Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys Trends Endocrinol Metab 9 1998 62 67
20. D.H. Abbott, D.A. Dumesic, and S. Franks Developmental origin of polycystic ovary syndrome - a hypothesis J Endocrinol 174 2002 1 5
21. S. Franks, M.I. McCarthy, and K. Hardy Development of polycystic ovary syndrome: involvement of genetic and environmental factors Int J Androl 29 2006 278 285
22. R.S. Legro, R. Spielman, M. Urbanek, D. Driscoll, J.F. Strauss 3rd, and A. Dunaif Phenotype and genotype in polycystic ovary syndrome Recent progress in hormone research 53 1998 217 256
23. J.M. Vink, S. Sadrzadeh, C.B. Lambalk, and D.I. Boomsma Heritability of polycystic ovary syndrome in a Dutch twin-family study J Clin Endocrinol Metab 91 2006 2100 2104
24. M.O. Goodarzi Looking for polycystic ovary syndrome genes: rational and best strategy Semin Reprod Med 26 2008 5 13
25. D.R. Stewart, B.A. Dombroski, M. Urbanek, W. Ankener, K.G. Ewens, and J.R. Wood Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity J Clin Endocrinol Metab 91 2006 4112 4117
26. K.G. Ewens, D.R. Stewart, W. Ankener, M. Urbanek, J.M. McAllister, and C. Chen Family-based analysis of candidate genes for polycystic ovary syndrome J Clin Endocrinol Metab 95 2010 2306 2315
27. G. Kosova, and M. Urbanek Genetics of the polycystic ovary syndrome Mol Cell Endocrinol 373 2013 29 38
28. G.B. Xie, P. Xu, Y.N. Che, Y.J. Xia, Y.X. Cao, and W.J. Wang Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis Reprod Biomed Online 26 2013 168 174
29. C.K. Welt, U. Styrkarsdottir, D.A. Ehrmann, G. Thorleifsson, G. Arason, and J.A. Gudmundsson Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry J Clin Endocrinol Metab 97 2012 E1342 E1347
30. M.O. Goodarzi, M.R. Jones, X. Li, A.K. Chua, O.A. Garcia, and Y.D. Chen Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts J Med Genet 49 2012 90 95
31. Z.J. Chen, H. Zhao, L. He, Y. Shi, Y. Qin, and Y. Shi Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 Nat Genet 43 2011 55 59
32. A. Capalbo, F. Sagnella, R. Apa, A.M. Fulghesu, A. Lanzone, and A. Morciano The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population Clin Endocrinol (Oxf) 77 2012 113 119
33. P. Mutharasan, E. Galdones, B. Peñalver Bernabé, O.A. Garcia, N. Jafari, and L.D. Shea Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry J Clin Endocrinol Metab 98 2013 E185 E190
34. M. Urbanek, S. Sam, R.S. Legro, and A. Dunaif Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype J Clin Endocrinol Metab 92 2007 4191 4198
35. N. Hatzirodos, R.A. Bayne, H.F. Irving-Rodgers, K. Hummitzsch, L. Sabatier, and S. Lee Linkage of regulators of TGF-β activity in the fetal ovary to polycystic ovary syndrome FASEB J 25 2011 2256 2265
36. L. Sabatier, N. Miosge, D. Hubmacher, G. Lin, E.C. Davis, and D.P. Reinhardt Fibrillin-3 expression in human development Matrix Biol 30 2011 43 52
37. N. Xu, S. Kwon, D.H. Abbott, D.H. Geller, D.A. Dumesic, and R. Azziz Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys PLoS One 6 2011 e27286
38. T. Massam-Wu, M. Chiu, R. Choudhury, S.S. Chaudhry, A.K. Baldwin, and A. McGovern Assembly of fibrillin microfibrils governs extracellular deposition of latent TGF beta J. Cell Sci 123 2010 3006 3018
39. G. Sengle, R.N. Ono, T. Sasaki, and L.Y. Sakai Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability J Biol Chem 286 2011 5087 5099
40. A.L. Marat, H. Dokainish, and P.S. McPherson DENN domain proteins: regulators of Rab GTPases J Biol Chem 286 2011 13791 13800
41. K. Tasaka, N. Masumoto, J. Mizuki, Y. Ikebuchi, M. Ohmichi, and H. Kurachi Rab3B is essential for GnRH-induced gonadotrophin release from anterior pituitary cells J Endocrinol 157 1998 267 274
42. R.E. Dickinson, A.J. Stewart, M. Myers, R.P. Millar, and W.C. Duncan Differential expression and functional characterization of luteinizing hormone receptor splice variants in human luteal cells: implications for luteolysis Endocrinology 150 2009 2873 2881
43. E. Dos Santos, M.N. Dieudonné, M.C. Leneveu, R. Pecquery, V. Serazin, and Y. Giudicelli In vitro effects of chorionic gonadotropin hormone on human adipose development J Endocrinol 194 2007 313 325
44. C. Pau, R. Saxena, and C.K. Welt Evaluating reported candidate gene associations with polycystic ovary syndrome Fertil Steril 99 2013 1774 1778
45. A. Dunaif Insulin action in the polycystic ovary syndrome Endocrinol Metab Clin North Am 28 1999 341 359
46. V.D. Lewy, K. Danadian, S.F. Witchel, and S. Arslanian Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome J Pediatr 138 2001 38 44
47. M.R. Palmert, C.M. Gordon, A.I. Kartashov, R.S. Legro, S.J. Emans, and A. Dunaif Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 1017 1023
48. A.D. Coviello, R.S. Legro, and A. Dunaif Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance J Clin Endocrinol Metab 91 2006 492 497
49. S.A. Arslanian, V. Lewy, K. Danadian, and R. Saad Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance J Clin Endocrinol Metab 87 2002 1555 1559
50. N. Lass, M. Kleber, K. Winkel, R. Wunsch, and T. Reinehr Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls J Clin Endocrinol Metab 96 2011 3533 3540
51. K.F. Nicandri, and K. Hoeger Diagnosis and treatment of polycystic ovarian syndrome in adolescents Curr Opin Endocrinol Diabetes Obes 19 2012 497 504
52. A.H. Roe, E. Prochaska, M. Smith, M. Sammel, and A. Dokras Using the Androgen Excess-PCOS Society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents J Pediatr 162 2013 937 941
53. R.M. Williams, K.K. Ong, and D.B. Dunger Polycystic ovarian syndrome during puberty and adolescence Mol Cell Endocrinol 373 2013 61 67
54. E. Carmina, S.E. Oberfield, and R.A. Lobo The diagnosis of polycystic ovary syndrome in adolescents Am J Obstet Gynecol 203 2010 201.e1 201.e5
55. L. Ibanez, N. Potau, I. Francois, and F. de Zegher Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth J Clin Endocrinol Metab 83 1998 3558 3562
56. M.J. Davies, W.A. March, K.J. Willson, L.C. Giles, and V.M. Moore Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood Hum Reprod 27 2012 1475 1480
57. M. Maliqueo, T. Sir-Petermann, V. Perez, B. Echiburu, A.L. de Guevara, and C. Galvez Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome J Clin Endocrinol Metab 94 2009 3282 3288
58. L. Ibáñez, N. Potau, and A. Carrascosa Insulin resistance, premature adrenarche, and a risk of the polycystic ovary syndrome (PCOS) Trends Endocrinol Metab 9 1998 72 77
59. C.R. McCartney, S.K. Blank, K.A. Prendergast, S. Chhabra, C.A. Eagleson, and K.D. Helm Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls J Clin Endocrinol Metab 92 2007 430 436
60. R.L. Rosenfield Clinical review: identifying children at risk for polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 787 796
61. E.E. Littlejohn, R.E. Weiss, D. Deplewski, D.V. Edidin, and R. Rosenfield Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome J Pediatr Endocrinol Metab 20 2007 41 51
62. D. Shi, and D.F. Vine Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk Fertil Steril 98 2012 185 193
63. K.A. Walters, C.M. Allan, and D.J. Handelsman Rodent models for human polycystic ovary syndrome Biol Reprod 86 2012 149 1-12
64. V. Padmanabhan, and A. Veiga-Lopez Sheep models of polycystic ovary syndrome phenotype Mol Cell Endocrinol 373 2013 8 20
65. D.H. Abbott, C.R. Bruns, D.K. Barnett, A. Dunaif, T.L. Goodfriend, D.A. Dumesic, and A.F. Tarantal Experimentally induced gestational androgen excess disrupts glucoregulation in rhesus monkey dams and their female offspring Am J Physiol Endocrinol Metab 299 2010 E741 E751
66. A.D. Abbott, R.J. Colman, R. Tiefenthaler, D.A. Dumesic, and D.H. Abbott Early-to-mid gestation fetal testosterone increases right hand 2D:4D finger length ratio in polycystic ovary syndrome-like monkeys PLoS One 7 2012 e42372
67. P. Beck-Peccoz, V. Padmanabhan, A.M. Baggiani, D. Cortelazzi, M. Buscaglia, and G. Medri Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone J Clin Endocrinol Metab 73 1991 525 532
68. T. Sir-Petermann, M. Maliqueo, B. Angel, H.E. Lara, F. Pérez-Bravo, and S.E. Recabarren Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization Hum Reprod 17 2002 2573 2579
69. M. Maliqueo, H.E. Lara, F. Sánchez, B. Echiburú, N. Crisosto, and T. Sir-Petermann Placental steroidogenesis in pregnant women with polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 166 2013 151 155
70. N. Crisosto, B. Echiburú, M. Maliqueo, V. Pérez, A. Ladrón de Guevara, and J. Preisler Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters Fertil Steril 97 2012 218 224
71. R. Hart, D.A. Doherty, R.J. Norman, S. Franks, J.E. Dickinson, M. Hickey, and D.M. Sloboda Serum antimüllerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS) Fertil Steril 94 2010 1118 1121
72. T. Sir-Petermann, E. Codner, V. Perez, B. Echiburu, M. Maliqueo, and A. Ladron de Guevara Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome J Clin Endocrinol Metab 94 2009 1923 1930
73. T. Sir-Petermann, A. Ladron de Guevara, E. Codner, J. Preisler, N. Crisosto, and B. Echiburu Relationship between anti-Mullerian hormone (AMH) and insulin levels during different Tanner stages in daughters of women with polycystic ovary syndrome Reprod Sci 19 2012 383 390
74. B. Cole, K. Hensinger, G.A. Maciel, R.J. Chang, and G.F. Erickson Human fetal ovary development involves the spatiotemporal expression of p450c17 protein J Clin Endocrinol Metab 91 2006 3654 3661
75. P.A. Fowler, R.A. Anderson, P.T. Saunders, H. Kinnell, J.I. Mason, and D.B. Evans Development of steroid signaling pathways during primordial follicle formation in the human fetal ovary J Clin Endocrinol Metab 96 2011 1754 1762
76. S. Palomba, R. Marotta, A.D. Cello, T. Russo, A. Falbo, and F. Orio Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study Clin Endocrinol (Oxf) 77 2012 898 904
77. J.A. Keelan, E. Mattes, H. Tan, A. Dinan, J.P. Newnham, and A.J. Whitehouse Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factors PLoS One 7 2012 e42827
78. J.A. Barry, A.R. Kay, R. Navaratnarajah, S. Iqbal, J.E. Bamfo, and A.L. David Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels J Obstet Gynaecol 30 2010 444 446
79. H. Anderson, N. Fogel, S.K. Grebe, R.J. Singh, R.L. Taylor, and A. Dunaif Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels J Clin Endocrinol Metab 95 2010 2180 2186
80. M. Hickey, D.M. Sloboda, H.C. Atkinson, D.A. Doherty, S. Franks, and R.J. Norman The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study J Clin Endocrinol Metab 94 2009 3714 3720
81. M.E. Lujan, T.G. Bloski, D.R. Chizen, D.C. Lehotay, and R.A. Pierson Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome Hum Reprod 25 2010 204 211
82. M.E. Lujan, A.J. Podolski, D.R. Chizen, D.C. Lehotay, and R.A. Pierson Digit ratios by computer-assisted analysis confirm lack of anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome Reprod Biol Endocrinol 18 2010 156
83. J.T. Manning, D. Scutt, D. Wilson, and D.I. Lewis-Jones The ratio of second to fourth digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen Hum Reprod 13 1998 3000 3004
84. M. McIntrye The use of digit ratios as markers for perinatal androgen action Reprod Biol Endocrinol 4 2006 10
85. Dean A, Sharpe RM. Anogenital distance or digit length ratio as measures of fetal androgen exposure: relationship to male reproductive development and its disorders. J Clin Endocrinol Metab. Published online April 8, 2013.
86. S. Franks Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction Endocrinology 153 2012 2536 2538
87. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat Rev Endocrinol 7 2011 219 231
88. F. de Zegher, and L. Ibáñez Early Origins of polycystic ovary syndrome: hypotheses may change without notice J Clin Endocrinol Metab 94 2009 3682 3685
89. M.E. Jones, W.C. Boon, K. McInnes, L. Maffei, C. Carani, and E.R. Simpson Recognizing rare disorders: aromatase deficiency Nat Clin Pract Endocrinol Metab 3 2007 414 421
90. A. Hertig, P. Liere, N. Chabbert-Buffet, J. Fort, A. Pianos, and B. Eychenne Steroid profiling in preeclamptic women: evidence for aromatase deficiency Am J Obstet Gynecol 203 2010 477.e1 477.e9
91. S.O. Jobe, C.T. Tyler, and R.R. Magness Aberrant synthesis, metabolism, and plasma accumulation of circulating estrogens and estrogen metabolites in preeclampsia implications for vascular dysfunction Hypertension 61 2013 480 487
92. H.B. Holt, S. Medbak, D. Kirk, R. Guirgis, I. Hughes, M.H. Cummings, and D.R. Meeking Recurrent severe hyperandrogenism during pregnancy: a case report J Clin Pathol 58 2005 439 442
93. F.R. Cattrall, B.J. Vollenhoven, and G.C. Weston Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome Fertil Steril 84 2005 1689 1692
94. A.L. Tapp, M.T. Maybery, and A.J. Whitehouse Evaluating the twin testosterone transfer hypothesis: a review of the empirical evidence Horm Behav 60 2011 713 722
95. E.A. Kuijper, J.M. Vink, C.B. Lambalk, and D.I. Boomsma Prevalence of polycystic ovary syndrome in women from opposite-sex twin pairs J Clin Endocrinol Metab 94 2009 1987 1990
96. D.J. Barker, C.N. Hales, C.H. Fall, C. Osmond, K. Phipps, and P.M. Clark Type 2 (noninsulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth Diabetologia 36 1993 62 67
97. C.N. Hales, and D.J. Barker The thrifty phenotype hypothesis Br Med Bull 60 2001 5 20
98. D. Jaquet, J. Leger, P. Czernichow, and C. Levy-Marchal The effect of in-utero undernutrition on the insulin resistance syndrome Curr Diabetes Rep 2 2002 77 82
99. Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study 1997;315:341-7.
100. N. Soto, R.A. Bazaes, V. Pena, T. Salazar, A. Avila, and G. Iniguez Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort J Clin Endocrinol Metab 88 2003 3645 3650
101. S. Cianfarani, D. Germani, and F. Branca Low birthweight and adult insulin resistance: the "catch-up growth" hypothesis Arch Dis Child Fetal Neonatal Ed 81 1999 F71 F73
102. K.K. Ong, C.J. Petry, P.M. Emmett, M.S. Sandhu, W. Kiess, and C.N. Hales Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels Diabetologia 47 2004 1064 1070
103. A. Bavdekar, C.S. Yajnik, C.H. Fall, S. Bapat, A.N. Pandit, and V. Deshpande Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48 1999 2422 2429
104. M.A. Veening, and M.M. Van Weissenbruch Delemarre-van de Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age J Clin Endocrinol Metab 87 2002 4657 4661
105. D. Jaquet, D.A. Tregouet, T. Godefroy, V. Nicaud, D. Chevenne, and L. Tiret Combined effects of genetic and environmental factors on insulin resistance associated with reduced fetal growth Diabetes 51 2002 3473 3478
106. B.L. Silverman, B.E. Metzger, N.H. Cho, and C.A. Loeb Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism Diabetes Care 18 1995 611 617
107. B.L. Silverman, T.A. Rizzo, N.H. Cho, B.E. Metzger Northwestern University Diabetes in Pregnancy Center Long-term effects of the intrauterine environment Diabetes Care 21 Suppl 2 1998 B142 B149
108. D. Dabelea, R.L. Hanson, R.S. Lindsay, D.J. Pettitt, G. Imperatore, and M.M. Gabir Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships Diabetes 49 2000 2208 2211
109. H.S.C.R. Group, B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, and U. Chaovarindr Hyperglycemia and adverse pregnancy outcomes N Engl J Med 358 2008 1991 2002
110. Group HSCR Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: associations with neonatal anthropometrics Diabetes 58 2009 453 459
111. L. Poretsky, N.A. Cataldo, Z. Rosenwaks, and L.C. Giudice The insulin-related ovarian regulatory system in health and disease Endocr Rev 20 1999 535 582
112. P. Moghetti, R. Castello, C. Negri, F. Tosi, G.G. Spiazzi, and E. Brun Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity J Clin Endocrinol Metab 81 1996 881 886
113. L. Ibanez, N. Potau, M. Zampolli, N. Prat, R. Virdis, E. Vicens-Calvet, and A. Carrascosa Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism J Clin Endocrinol Metab 81 1996 1237 1243
114. F. Mehrabian, and R. Kelishadi Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls J Res Med Sci 17 2012 207 211
115. T. Sir-Petermann, C. Hitchsfeld, M. Maliqueo, E. Codner, B. Echiburú, and R. Gazitúa Birth weight in offspring of mothers with polycystic ovarian syndrome Hum Reprod 20 2005 2122 2126
116. L. Ibanez, A. Ferrer, M.V. Marcos, F.R. Hierro, and F. de Zegher Early puberty: rapid progression and reduced final height in girls with low birth weight Pediatrics 106 2000 E72
117. L. Ibanez, R. Jimenez, and F. de Zegher Early puberty-menarche after precocious pubarche: relation to prenatal growth Pediatrics 117 2006 117 121
118. L. Ibanez, A. Lopez-Bermejo, M. Diaz, and F. de Zegher Catch-up growth in girls born small for gestational age precedes childhood progression to high adiposity Fertil Steril 96 2011 220 223
119. V.H. Boonstra, P.G. Mulder, F.H. de Jong, and A.C. Hokken-Koelega Serum dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment J Clin Endocrinol Metab 89 2004 712 717
120. T. Meas, D. Chevenne, E. Thibaud, J. Leger, S. Cabrol, and P. Czernichow Endocrine consequences of premature pubarche in post-pubertal Caucasian girls Clin Endocrinol 57 2002 101 106
121. D. Jaquet, J. Leger, D. Chevenne, P. Czernichow, and C. Levy-Marchal Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women J Clin Endocrinol Metab 84 1999 3945 3949
122. K.K. Ong, N. Potau, C.J. Petry, R. Jones, A.R. Ness, and J.W. Honour Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls J Clin Endocrinol Metab 89 2004 2647 2651
123. K.A. Neville, and J.L. Walker Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity Arch Dis Child 90 2005 258 261
124. L. Ibanez, A. Lopez-Bermejo, M. Diaz, M.V. Marcos, and F. de Zegher Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence J Clin Endocrinol Metab 96 2011 E1262 E1267
125. L. Ibáñez, N. Potau, G. Enriquez, M.V. Marcos, and F. de Zegher Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age Hum Reprod 18 2003 1565 1569
126. M.I. Hernandez, A. Martinez, T. Capurro, V. Pena, L. Trejo, and A. Avila Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results J Clin Endocrinol Metab 91 2006 3377 3381
127. A.J. Lem, V.H. Boonstra, J.S. Renes, P.E. Breukhoven, F.H. de Jong, and J.S. Laven Anti-müllerian hormone in short girls born small for gestational age and the effect of growth hormone treatment Human Reproduction 26 2011 898 903
128. T. Sir-Petermann, L. Marquez, M. Carcamo, C. Hitschfeld, E. Codner, and M. Maliqueo Effects of birth weight on antimullerian hormone serum concentrations in infant girls J Clin Endocrinol Metab 95 2010 903 910
129. C.P. Hagen, L. Aksglaede, K. Sørensen, A. Mouritsen, A.M. Andersson, and J.H. Petersen Individual serum levels of anti-müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study Hum Reprod 27 2012 861 866
130. J.L. Cresswell, D.J. Barker, C. Osmond, P. Egger, D.I. Phillips, and R.B. Fraser Fetal growth, length of gestation, and polycystic ovaries in adult life Lancet 350 1997 1131 1135
131. C. Puche, M. José, A. Cabero, and A. Meseguer Expression and enzymatic activity of the P450c17 gene in human adipose tissue Eur J Endocrinol 146 2002 223 229
132. E.E. Kershaw, and J.S. Flier Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
133. A. Larnkjær, H.K. Ingstrup, L. Schack-Nielsen, C. Mølgaard, and K.F. Michaelsen Thin newborns are more insulin resistant at 10 years of age Acta Paediatr 100 2011 511 514
134. P.B. Kaplowitz, E.J. Slora, R.C. Wasserman, S.E. Pedlow, and M.E. Herman-Giddens Earlier onset of puberty in girls: relation to increased body mass index and race Pediatrics 108 2001 347 353
135. S. Arslanian, and C. Suprasongsin Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab 81 1996 1058 1062
136. F. Bacha, R. Saad, N. Gungor, J. Janosky, and S.A. Arslanian Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors J Clin Endocrinol Metab 88 2003 2534 2540
137. T.S. Hannon, J. Janosky, and S.A. Arslanian Longitudinal study of physiologic insulin resistance and metabolic changes of puberty Pediatr Res 60 2006 759 763
138. J.E. Nestler, D.J. Jakubowicz, A.F. de Vargas, C. Brik, N. Quintero, and F. Medina Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system J Clin Endocrinol Metab 83 1998 2001 2005
139. R.L. Rosenfield Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair J Pediatr 79 1971 260 266
140. P. Vuguin, B. Linder, R.G. Rosenfeld, P. Saenger, and J. DiMartino-Nardi The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche J Clin Endocrinol Metab 84 1999 2037 2042
141. C.R. McCartney, K.A. Prendergast, S. Chhabra, C.A. Eagleson, R. Yoo, and R.J. Chang The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism J Clin Endocrinol Metab 91 2006 1714 1722
142. K.L. Knudsen, S.K. Blank, C. Burt Solorzano, J.T. Patrie, R.J. Chang, and S. Caprio Hyperandrogenemia in obese peripubertal girls: correlates and potential etiological determinants Obesity 18 2010 2118 2124
143. R.L. Rosenfield Polycystic ovary syndrome and insulin-resistant hyperinsulinemia J Am Acad Dermatol 45 3 Suppl 2001 S95 104
144. M. Jabbar, M. Pugliese, P. Fort, B. Recker, and F. Lifshitz Excess weight and precocious pubarche in children: alterations of the adrenocortical hormones J Am Coll Nutr 10 1991 289 296
145. D. Apter, T. Butzow, G.A. Laughlin, and S.S. Yen Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism J Clin Endocrinol Metab 80 1995 2966 2973
146. C.R. McCartney, K.A. Prendergast, S.K. Blank, K.D. Helm, S. Chhabra, and J.C. Marshall Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls J Clin Endocrinol Metab 94 2009 56 66
147. R.L. Rosenfield, and B. Bordini Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity Brain Res 1364 2010 186 197
148. C.M. Burt Solorzano, C.R. McCartney, S.K. Blank, K.L. Knudsen, and J.C. Marshall Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion BJOG 117 2010 143 149
149. S.K. Blank, C.R. McCartney, S. Chhabra, K.D. Helm, C.A. Eagleson, and R.J. Chang Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls - implications for regulation of pubertal maturation J Clin Endocrinol Metab 94 2009 2360 2366
150. W.K. McGee, C.V. Bishop, A. Bahar, C.R. Pohl, R.J. Chang, and J.C. Marshall Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndrome Hum Reprod 27 2012 531 540
151. M.D. Kahsar-Miller, C. Nixon, L.R. Boots, R.C. Go, and R. Azziz Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS Fertil Steril 75 2001 53 58
152. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
153. S.C. Kent, C.L. Gnatuk, A.R. Kunselman, L.M. Demers, P.A. Lee, and R.S. Legro Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study J Clin Endocrinol Metab 93 2008 1662 1669
154. T. Sir-Petermann, M. Maliqueo, E. Codner, B. Echiburu, N. Crisosto, and V. Perez Early metabolic derangements in daughters of women with polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 4637 4642
155. S. Franks, L.J. Webber, M. Goh, A. Valentine, D.M. White, G.S. Conway, S. Wiltshire, and M.I. McCarthy Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries J Clin Endocrinol Metab 93 2008 3396 3402
156. B.O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar Glucose intolerance,
157. J.P. Baillargeon, and A.C. Carpentier Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects Diabetologia 50 2007 2424 2432
158. T. Sir-Petermann, B. Angel, M. Maliqueo, F. Carvajal, J.L. Santos, and F. Perez-Bravo Prevalence of type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome Diabetologia 45 2002 959 964
159. A. Trottier, M.C. Battista, D.H. Geller, B. Moreau, A.C. Carpentier, J. Simoneau-Roy, and J.P. Baillargeon Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome Fertil Steril 98 2012 1627 1634
160. N. Raissouni, A. Kolesnikov, R. Purushothaman, S. Sinha, S. Bhandari, and A. Bhangoo Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome Int J Pediatr Endocrinol 2012 2012 14